AZN

Astrazeneca plc

Jan 30, 2026

187.10

+3.93 2.15 %

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Today, 7:06 AMAstraZeneca announces its ordinary shares and certain US bonds have begun trading on the New York Stock Exchange under a harmonized cross-listing structure, completing its transition from Nasdaq ADRs.

Scroll to Statements

Index	-	P/E	31.07	EPS (ttm)	6.02	Insider Own	-	Shs Outstand	1.55B	Perf Week	5.41%
Market Cap	-	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	1.48B	Perf Month	3.46%
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	9.49%
Income	9.40B	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	32.32%
Sales	58.13B	P/B	6.32	EPS next Y	-	ROA	8.57%	Short Interest	-	Perf YTD	6.61%
Book/sh	29.60	P/C	-	EPS next 5Y	-	ROE	21.70%	52W High	- -	Perf Year	41.05%
Cash/sh	-	P/FCF	-	EPS past 3/5Y	285.86% 34.63%	ROIC	13.06%	52W Low	- -	Perf 3Y	54.69%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.64% 17.27%	Gross Margin	73.23%	Volatility	3.86% 2.56%	Perf 5Y	77.09%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	21.86%	ATR (14)	6.88	Perf 10Y	306.74%
Dividend Ex-Date	-	Quick Ratio	0.69	Sales Y/Y TTM	13.52%	Profit Margin	16.17%	RSI (14)	53.34	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.88	EPS Q/Q	77.36%	SMA20	-	Beta	-	Target Price	104.93
Payout	69.15%	Debt/Eq	0.71	Sales Q/Q	11.99%	SMA50	-	Rel Volume	-	Prev Close	183.17
Employees	94300	LT Debt/Eq	0.57	Earnings	-	SMA200	-	Avg Volume	1.77K	Price	187.10
IPO	Oct 17, 2003	Option/Short	Yes / No	EPS/Sales Surpr.	- -	Trades		Volume	1,738	Change	2.15%

Today 07:00AM	AstraZeneca begins trading on the New York Stock Exchange (Business Wire)
02:46AM	AstraZeneca Shares to Start Trading in US After Listing Upgrade (Bloomberg)
Jan-30-26 12:28PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:11AM	Block quotes in PNR test (Test Provider for Finance)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company's history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc

Upgrade your FINVIZ experience